The Business Times
SUBSCRIBERS

Patients fear spike in price of old drugs

Wall Street-traded pharma firm seeks approval for modified version of drug given free by family-run company

Published Wed, Dec 23, 2015 · 09:50 PM
Share this article.

New York

FRED Kellerman, a retired car salesman from Los Angeles, was bedridden with a rare neuromuscular disease when he started taking a drug in the 1990s at Duke University in North Carolina. It changed his life.

"I had to have a wheelchair to get onto the airplane, but by the time I left, I could walk on," he said.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here